Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors

G Leclercq, N Steinhoff, H Haegel, D De Marco… - …, 2022 - Taylor & Francis
ABSTRACT T cell engaging therapies, like CAR-T cells and T cell engagers, redirect T cells
toward tumor cells, facilitating the formation of a cytotoxic synapse and resulting in …

African swine fever virus infection and cytokine response in vivo: an update

G Franzoni, M Pedrera, PJ Sánchez-Cordón - Viruses, 2023 - mdpi.com
African swine fever (ASF) is a hemorrhagic viral disease of domestic pigs and wild suids (all
Sus scrofa) caused by the ASF virus (ASFV). The disease is spreading worldwide without …

Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology

M Wang, F Yu, W Chang, Y Zhang, L Zhang… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a contagious respiratory
virus that is the cause of the coronavirus disease 2019 (COVID-19) pandemic which has …

Mechanisms of SARS-CoV-2 infection-induced kidney injury: A literature review

W He, X Liu, B Hu, D Li, L Chen, Y Li, Y Tu… - Frontiers in cellular …, 2022 - frontiersin.org
The severe acute respiratory coronavirus 2 (SARS-CoV-2) has become a life-threatening
pandemic. Clinical evidence suggests that kidney involvement is common and might lead to …

Dissecting the mechanisms underlying the cytokine release syndrome (CRS) mediated by T-cell bispecific antibodies

G Leclercq-Cohen, N Steinhoff, L Albertí Servera… - Clinical Cancer …, 2023 - AACR
Purpose: Target-dependent TCB activity can result in the strong and systemic release of
cytokines that may develop into cytokine release syndrome (CRS), highlighting the need to …

[HTML][HTML] Impaired immune response drives age-dependent severity of COVID-19

J Beer, S Crotta, A Breithaupt, A Ohnemus… - Journal of Experimental …, 2022 - rupress.org
Severity of COVID-19 shows an extraordinary correlation with increasing age. We generated
a mouse model for severe COVID-19 and show that the age-dependent disease severity is …

Cell‐based drug delivery systems participate in the cancer immunity cycle for improved cancer immunotherapy

X Fan, K Wang, Q Lu, Y Lu, J Sun - Small, 2023 - Wiley Online Library
Immunotherapy aims to activate the cancer patient's immune system for cancer therapy. The
whole process of the immune system against cancer referred to as the “cancer immunity …

Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery

X Jiang, L Wu, M Zhang, T Zhang, C Chen, Y Wu… - Journal of Controlled …, 2023 - Elsevier
Chemotherapeutic drugs have been found to activate the immune response against tumors
by inducing immunogenic cell death, in addition to their direct cytotoxic effects toward …

Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study

A Tufa, TH Gebremariam, T Manyazewal… - Frontiers in …, 2022 - frontiersin.org
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may
represent disease severity. We aimed to assess plasma inflammatory mediator …

Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury

GP Fadanni, JB Calixto - Cytokine & Growth Factor Reviews, 2023 - Elsevier
Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …